Pasinex Files Amended National Instrument 43-101 Technical Report for the Pinargozu Mine
TORONTO, Jan. 30, 2019 (GLOBE NEWSWIRE) — Pasinex Resources Limited (CSE: PSE) (FSE: PNX) (“the Company”) announces that it has […]
TORONTO, Jan. 30, 2019 (GLOBE NEWSWIRE) — Pasinex Resources Limited (CSE: PSE) (FSE: PNX) (“the Company”) announces that it has […]
Monaco, Jan. 30, 2019 (GLOBE NEWSWIRE) — GasLog Partners LP (“GasLog Partners” or the “Partnership”) (NYSE: GLOP), an international owner […]
GAAP loss from continuing operations per share of $1.49 vs. $0.35 in prior year Non-GAAP adjusted loss per share of […]
~ Company to Host Investor Call on Friday, February 8, 2019 at 8:30 a.m. ET to Discuss Updated Clinical Data […]
2018 net revenues1 were $2,526 million, an increase of 5% compared to 2017, resulting from 8% organic growth partially offset […]
NEW YORK, Jan. 30, 2019 (GLOBE NEWSWIRE) — The Board of Directors of Nasdaq, Inc. (Nasdaq: NDAQ) has declared a […]
CHESTERBROOK, Pa., Jan. 30, 2019 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN) (the “Company”) today announced that it entered into […]
Topline results anticipated in 2Q 2019 NEW YORK, Jan. 30, 2019 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a […]
REHOVOT, Israel, Jan. 30, 2019 (GLOBE NEWSWIRE) — Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, announced […]
MIST-1 study met primary endpoint First-in-class fixed combination mydriatic agent demonstrated robust efficacy, high tolerability; Study further validates OpteJet™ platform […]